Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
State Street SPDR S&P Biotech ETF
(NY:
XBI
)
124.49
-0.16 (-0.13%)
Streaming Delayed Price
Updated: 9:41 AM EST, Feb 12, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
523,454
Open
125.16
Bid (Size)
124.47 (200)
Ask (Size)
124.50 (200)
Prev. Close
124.65
Today's Range
124.22 - 125.61
52wk Range
66.66 - 132.09
Shares Outstanding
541,500
Dividend Yield
1.31%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
VKTX Stock Rallies After Hours On Optimism Around Company’s Obesity Pipeline
↗
February 11, 2026
The company shared optimistic timelines for advancing the clinical studies of both oral and subcutaneous VK2735 in obesity.
Via
Stocktwits
Biotech Beat Nvidia in 2025. Can It Do It Again?
↗
February 11, 2026
Big pharma and biotech take the earnings stage with reports from Eli Lilly and Novo Nordisk leading the lineup. Will they help the industry once again outperform AI champ Nvidia?
Via
The Motley Fool
Topics
Artificial Intelligence
Performance
YTD
+2.4%
+2.4%
1 Month
+0.5%
+0.5%
3 Month
+9.1%
+9.1%
6 Month
+39.1%
+39.1%
1 Year
+39.8%
+39.8%
More News
Read More
Sector Alert: 4 Healthcare ETFs Poised for Explosive Growth Now
↗
February 11, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
ETFs
Economy
Why Did UPB Stock Pop 20% In Pre-Market Today?
↗
February 11, 2026
Via
Stocktwits
Why IBRX Stock Is One Of The Biggest Pre-Market Movers Today
↗
January 16, 2026
Via
Stocktwits
IBRX Stock Finds Retail Cheer After Company’s Immunotherapy For Bladder Cancer Gets Saudi FDA Approval
↗
January 14, 2026
Via
Stocktwits
Why Did NRXP Stock Surge 21% Pre-Market Today?
↗
January 14, 2026
Via
Stocktwits
Why Did RGNX Shares Plummet 19% After-Hours Today?
↗
February 09, 2026
Via
Stocktwits
MDXG Stock Rises As MiMedx Enters Into Exclusive Distribution Agreement For Three Products
↗
February 04, 2026
Via
Stocktwits
Topics
Artificial Intelligence
RGNX Stock Is Falling Today — What Is The FDA Update On REGENXBIO's Gene Therapy?
↗
January 28, 2026
Via
Stocktwits
Why Did MNKD Stock Jump Over 7% In Pre-Market Today?
↗
January 26, 2026
Via
Stocktwits
IBRX Garners Retail Attention On Positive Update In Immunotherapy For Lung Cancer Patients
↗
January 13, 2026
Via
Stocktwits
Why Did TVTX Stock Crash 30% In Pre-Market Today?
↗
January 13, 2026
Via
Stocktwits
IMRX Stock Closed Over 20% Higher Today: Here’s Why
↗
January 07, 2026
Via
Stocktwits
The Biotech Renaissance: Scientific Breakthroughs and M&A Frenzy Spark a New Bull Market
January 22, 2026
Via
MarketMinute
Topics
Artificial Intelligence
ETFs
Initial Public Offering
Why NVAX Stock Is Popping Pre-Market – And What Does Pfizer Have To Do With It?
↗
January 20, 2026
Via
Stocktwits
Why Did GLUE Stock Surge Over 50% In Premarket Today?
↗
January 07, 2026
Via
Stocktwits
Healthcare Sector Falters: S&P 500's Biggest Loser Amid Broader Market Caution
December 09, 2025
Via
MarketMinute
Topics
ETFs
Economy
Intellectual Property
Eaton, FTAI Aviation And More On CNBC's 'Final Trades'
↗
November 28, 2025
Via
Benzinga
Topics
ETFs
Stocks
Biotech Insiders Are Spending Billions. Trump Favors Less Oversight. One Biotech ETF Could Ride the Surge.
↗
November 17, 2025
Via
The Motley Fool
Topics
ETFs
Economy
Government
Money Moving Into Healthcare Not AI; Four Fed Presidents Do Not Want a Rate Cut; Euphoria Wearing Off
↗
November 13, 2025
Via
Benzinga
Topics
Economy
Taiwan Semiconductor, HealthEquity, Cboe Global Markets And More: CNBC's 'Final Trades'
↗
November 13, 2025
Via
Benzinga
Biotech ETFs Come Alive As Illumina Soars 23% — Is The Genomics Winter Finally Over?
↗
November 03, 2025
Via
Benzinga
Topics
ETFs
FDA Turmoil Spills Over To Aurinia Pharma As Lawsuit Targets Ex-Drug Review Chief — Retail Traders Cry ‘Stock Manipulation’
↗
November 02, 2025
Via
Stocktwits
Topics
Lawsuit
Top 6 ETFs To Watch As Wall Street's Strongest Six Months Begin
↗
October 30, 2025
Via
Benzinga
Topics
Artificial Intelligence
ETFs
Frequently Asked Questions
Is State Street SPDR S&P Biotech ETF publicly traded?
Yes, State Street SPDR S&P Biotech ETF is publicly traded.
What exchange does State Street SPDR S&P Biotech ETF trade on?
State Street SPDR S&P Biotech ETF trades on the New York Stock Exchange
What is the ticker symbol for State Street SPDR S&P Biotech ETF?
The ticker symbol for State Street SPDR S&P Biotech ETF is XBI on the New York Stock Exchange
What is the current price of State Street SPDR S&P Biotech ETF?
The current price of State Street SPDR S&P Biotech ETF is 124.49
When was State Street SPDR S&P Biotech ETF last traded?
The last trade of State Street SPDR S&P Biotech ETF was at 02/12/26 09:41 AM ET
What is the market capitalization of State Street SPDR S&P Biotech ETF?
The market capitalization of State Street SPDR S&P Biotech ETF is 67.41M
How many shares of State Street SPDR S&P Biotech ETF are outstanding?
State Street SPDR S&P Biotech ETF has 67M shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
